Federal Register / Vol. 83, No. 141 / Monday, July 23, 2018 / Notices 34879 

The company plans to import the 

listed controlled substance for narcotic 

material for bulk manufacture. 

Dated: July 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–15750 Filed 7–20–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Applications: Shertech Laboratories, 

LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 22, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 22, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on April 

23, 2018, Shertech Laboratories, LLC, 

1185 Woods Chapel Road, Duncan 

South Carolina 29334 applied to be 

registered as an importer of the 

following basic class of controlled 

substance: 

Controlled substance Drug 

Code Schedule 

Cocaine ........................ 9041 II 

The company plans to import 

synthetic derivatives of the listed 

controlled substance in bulk form to 

conduct clinical trials. 

Approval of permit applications will 

occur only when the registrant’s activity 

is consistent with what is authorized 

under to 21 U.S.C.952 (a)(2). 

Authorization will not extend to the 

import of FDA approved or nonapproved finished dosage forms for 

commercial sale. 

Dated: July 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–15713 Filed 7–20–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Fisher Clinical Services, 

Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 22, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 22, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on June 5, 

2018, Fisher Clinical Services, 700A–C 

Nestle Way, Breinigsville, PA 18031– 

1522 applied to be registered as an 

importer of the following basic class of 

controlled substance: 

Controlled substance Drug 

code Schedule 

Psilocybin ..................... 7437 I 

The company plans to import the 

listed controlled substance for clinical 

trials. 

Dated: July 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–15667 Filed 7–20–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Registration 

ACTION: Notice of registration. 

SUMMARY: The registrant listed below 

has applied for and been granted 

registration by the Drug Enforcement 

Administration (DEA) as an importer of 

various classes of schedule I or II 

controlled substances. 

SUPPLEMENTARY INFORMATION: 

The company listed below applied to 

be registered as an importer of various 

basic classes of controlled substances. 

Information on the previously published 

notice is listed in the table below. No 

comments or objections were submitted 


amozie on DSK3GDR082PROD with NOTICES1
34880 Federal Register / Vol. 83, No. 141 / Monday, July 23, 2018 / Notices 

and no requests for hearing were 

submitted for this notice. 

Company FR Docket Published 

United States Pharmacopeial Convention .............................................. 83 FR 15175 .................................. April 9, 2018. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823, 952(a) and 

958(a) and determined that the 

registration of the listed registrant to 

import the applicable basic classes of 

schedule I or II controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated this company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing the company’s physical security 

systems, verifying the company’s 

compliance with state and local laws, 

and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

952(a) and 958(a), and in accordance 

with 21 CFR 1301.34, the DEA has 

granted a registration as an importer for 

schedule I or II controlled substances to 

the above listed company. 

Dated: July 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–15665 Filed 7–20–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Registration 

ACTION: Notice of registration. 

SUMMARY: Registrants listed below have 

applied for and been granted 

registration by the Drug Enforcement 

Administration (DEA) as importers of 

various classes of schedule I or II 

controlled substances. 

SUPPLEMENTARY INFORMATION: The 

companies listed below applied to be 

registered as importers of various basic 

classes of controlled substances. 

Information on previously published 

notices is listed in the table below. No 

comments or objections were submitted 

and no requests for hearing were 

submitted for these notices. 

Company FR Docket Published 

Novitium Pharma, LLC ....................................................................... 83 FR 13520 ............................... March 29, 2018. 

Rhodes Technologies ........................................................................ 83 FR 22517 ............................... May 15, 2018. 

Xcelience ............................................................................................ 83 FR 22519 ............................... May 15, 2018. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823, 952(a) and 

958(a) and determined that the 

registration of the listed registrants to 

import the applicable basic classes of 

schedule I or II controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated each company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing each company’s physical 

security systems, verifying each 

company’s compliance with state and 

local laws, and reviewing each 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

952(a) and 958(a), and in accordance 

with 21 CFR 1301.34, the DEA has 

granted a registration as an importer for 

schedule I or II controlled substances to 

the above listed companies. 

Dated: July 12, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–15666 Filed 7–20–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Johnson 

Matthey Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 21, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on May 31, 

2018, Johnson Matthey Inc., 2003 Nolte 

Drive, West Deptford, New Jersey 

08066–1742 applied to be registered as 

a bulk manufacturer of the following 

basic class of controlled substance: 

Controlled 

substance Drug code Schedule 

Opium tincture ...... 9630 II 

The company plans to manufacture 

the above-listed controlled substance in 

bulk for distribution to its customers. 


amozie on DSK3GDR082PROD with NOTICES1